A gentler way to ask the biggest question.
NIFTY® is a non-invasive prenatal test developed by BGI and offered in the region in partnership with . From a small maternal blood sample, it screens for the most common chromosomal conditions with over 99% accuracy — from as early as week 10.
Reliable
Up to 99% sensitivity and specificity, validated by clinical studies worldwide.
Safe
Non-invasive with no risk of miscarriage — only maternal blood is required.
Simple
Just 6–10 mL of venous blood collected from the pregnant woman by a clinician.
Comprehensive
Screens 22 trisomies, 4 sex chromosome abnormalities, 84 microdeletion/duplication syndromes, and fetal sex.
Fast
Reports issued in 5–7 working days to help physicians make rapid clinical decisions.
One test. A comprehensive picture.
Chromosomal trisomies
Including T21, T18, T13
Sex chromosome abnormalities
XO, XXX, XXY, XYY
Microdeletion / duplication syndromes
Across all chromosomes
Fetal sex determination
On request